A Study of Comparative Formulations of Niraparib and Abiraterone Acetate (AA) in Men With Prostate Cancer
Clinical trial NCT04577833 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04577833
- Sponsor
- Janssen Research & Development, LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-13
- Primary completion
- 2021-10-15
- Enrollment
- 136
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.